Imports of Bulk Drugs from China grew 8.8 %

Last Updated on October 15, 2024 by The Health Master

Bulk Drugs

India’s pharmaceutical industry, a global powerhouse, continues to show a growing dependence on China for its supply of bulk drugs and drug intermediates.

The first quarter of the current fiscal year has seen a significant uptick in imports from the neighboring nation.

Imports Surge, China’s Share Grows

Overall imports of bulk drugs and drug intermediates to India rose by a commendable 8.84% during the April-June 2024 quarter compared to the same period last year.

However, it’s the import figures from China that truly stand out.

These imports experienced a robust 10.8% growth, solidifying China’s position as India’s primary supplier in this critical sector.

• Dominant Chinese Share: China’s contribution to India’s bulk drug imports is staggering, accounting for a massive 72-74% of the total imports during the quarter.
• Quantity Matters: Not only in value but also in volume, China holds a commanding position, supplying 79.4% of the total quantity of bulk drugs and drug intermediates imported by India.

Financial Implications of the Import Trend

The financial data paints a clear picture of India’s growing import bill for bulk drugs.

• Dollar Value: Total imports climbed to $1.16 billion in the first quarter of 2024-25 from $1.07 billion in the same period last year.
• Chinese Imports: India’s import bill from China surged to $858.70 million, up from $774.96 million in the previous year.
• Rupee Terms: The import value in Indian Rupees also witnessed a substantial increase, reaching Rs. 9,712.44 crore compared to Rs. 8,824.64 crore in the corresponding quarter of the previous fiscal.

A Mixed Bag for Indian Drug Exports

While the import scenario is dominated by China, India’s drug exports have shown a more modest performance.

• Slight Export Growth: Bulk drug and intermediate exports grew marginally to $1.13 billion (Rs. 9,447.32 crore) in the first quarter of 2024-25 from $1.12 billion (Rs. 9,253.92 crore) in the same period last year.
• Quantity Stagnation: The quantity of exports remained relatively unchanged at 1.10 lakh metric tonnes.

Broader Pharmaceutical Trade Scenario

To get a complete picture, it’s essential to look at the overall drug and pharmaceutical trade.

• Export Growth: The broader category of drugs and pharmaceuticals witnessed a 9.3% export growth in the first quarter, reaching $7.20 billion.
• Import Rise: However, imports in this sector also jumped by 12.4% to $2.15 billion.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

• CDSCO Nod granted to Conduct Clinical Trial of Ruxolitinib cream
  November 4, 2024
• No provision for separate license for Pharma marketers
  November 4, 2024
• Important short notes for Industry
  November 3, 2024
• Deadly reactor explosion at Pharma Plant in Andhra Pradesh
  November 3, 2024
• Drug recall: Dr Reddy’s recalls Cinacalcet Tablets due to impurity Concerns
  November 3, 2024
• Indian Pharma Industry to face New GMP Regulations Compliance
  November 1, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: